Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Posted:
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States.
This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis.
In an NHS survey of 303 senior doctors, 60 per cent said they would be interested in working for the online service, alongside their existing roles, when it starts next year.
Read more here.
The UCL Centre for Digital Public Health in Emergencies (dPHE) has been designated a World Health Organisation (WHO) Collaborating Centre for Digital Public Health and Pandemic Preparedness.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us